Skip to main content

Arsonoliposomes: Preparation and Physicochemical Characterization

  • Protocol
  • First Online:
Liposomes

Part of the book series: Methods in Molecular Biology ((MIMB,volume 605))

Abstract

Arsonoliposomes (ARSL) which are liposomes that contain arsonolipids in their membranes have shown interesting anticancer and antiparasitic activity in vitro. Their lipid composition (the specific arsonolipids and/or phospholipids used for their preparation, and the relative amounts of each lipid type) highly influences their physicochemical properties as well as their in vivo kinetics and antiparasitic activity; however, their cytotoxicity towards cancer cells is minimally – if at all – modified. ARSL are prepared by a modification of the “one step” method followed or not by sonication (for formation of sonicated or non-sonicated ARSL, respectively). Arsonoliposomes may be composed only of arsonolipids (containing or not cholesterol) [plain ARSL], or they may contain mixtures of arsonolipids with phospholipids (with or without Chol) [mixed ARSL]. Herein, we describe in detail the preparation and physicochemical characterization of ARSL.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

Ars:

Arsonolipid

ARSL:

Arsonoliposome

As:

Arsenic

C6:

Brain Glioma cell line (Rat)

CF:

5,6-Carboxyfluorescein

Chol:

Cholesterol

Cryo-EM:

Cryo electron microscopy

DMSO:

Dimethyl sulfoxide

DPPC:

1,2-Dipalmitoyl-sn-glyceroyl-3-phosphocholine

DPPE-PEG2000:

1,2-Dipalmitoyl-sn-glyceroyl-3-phosphoethanolamine conjugated to polyethylene glycol (MW 2000)

DSPC:

1,2-Distearoyl-sn-glyceroyl-3-phosphocholine

DSPE-PEG2000:

1,2-Distearoyl-sn-glyceroyl-3-phosphoethanolamine conjugated to polyethylene glycol (MW 2000)

EDTA:

Ethylenediamine tetraacetic acid

EM:

Electron microscopy

FCS:

Fetal calf serum

GH3:

Pituitary tumor cells

HL-60:

Human leukemia cell line

HUVEC:

Human umbilical vein endothelial cell

IC50:

50% Growth inhibition concentration

MEC:

Minimum effective concentration

NB4:

Human leukemia cell line

P:

Phosphorus

PBS:

Phosphate buffered saline

PC:

Phosphatidylcholine

PC3:

Prostate cancer cell line

PCS:

Photon correlation spectroscopy

PEG:

Polyethylene glycol

SUV:

Small unilamellar vesicles

TBS:

Tris-buffered saline

References

  1. Dembitsky VM, Levitsky DO (2004) Arsenolipids. Prog Lipid Res 43:403–448

    Article  CAS  PubMed  Google Scholar 

  2. Serves SV, Sotiropoulos DN, Ioannou PV, Jain MK (1993) One pot synthesis of arsonolipid via thioarsenite precursors. Phosphorous Sulfur Silicon 81:181–190

    Article  CAS  Google Scholar 

  3. Tsivgoulis GM, Ioannou PV (2008) A reinvestigation of the synthesis of arsonolipids (2, 3-diacyloxypropylarsonic acids). Chem Phys Lipids 152:113–121

    Article  CAS  PubMed  Google Scholar 

  4. Serves SV, Charalambidis YC, Sotiropoulos DN, Ioannou PV (1995) Reaction of arsenic (III) oxide, arsenous and arsenic acids with thiols. Phosphorous Sulfur Silicon 105:109–116

    Article  CAS  Google Scholar 

  5. Timotheatou D, Ioannou PV, Scozzafava A, Briganti F, Supuran CT (1996) Carnonic anhydrase interaction with lipothioasrenites: a novel class of isozymes I and II inhibitors. Met Based Drugs 3:263–268

    Article  CAS  PubMed  Google Scholar 

  6. Kigawa J, Minagawa Y, Kanamori Y, Itamochi H, Cheng X, Okada M, Oishi T, Terakawa N (1998) Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer. Cancer 82:697–702

    Article  CAS  PubMed  Google Scholar 

  7. Serves SV, Tsivgoulis GM, Sotiropoulos DN, Ioannou PV, Jain MK (1992) Synthesis of (R)- and (S)-1, 2-diacyloxypropyl-3-arsonic acids: optically active arsonolipids. Phosphorous Sulfur Silicon 71:99–105

    Article  CAS  Google Scholar 

  8. Talsma H, Van Steenbergen M, Borchert J, Crommelin D (1994) A novel technique for the one-step preparation of liposomes and non-ionic surfactant vesicles in a continuous gas stream: the ‘bubble method’. J Pharm Sci 83:276–280

    Article  CAS  PubMed  Google Scholar 

  9. Fatouros D, Gortzi O, Klepetsanis P, Antimisiaris SG, Stuart MCA, Brisson A, Ioannou PV (2001) Preparation and properties of arsonolipid containing liposomes. Chem Phys Lipids 109:75–89

    Article  CAS  PubMed  Google Scholar 

  10. Piperoudi S, Fatouros D, Ioannou PV, Frederik P, Antimisiaris SG (2006) Incorporation of PEG-lipids in arsonoliposomes can produce highly stable arsenic-containing vesicles of specific lipid composition. Chem Phys Lipids 139:96–106

    Article  CAS  PubMed  Google Scholar 

  11. Piperoudi S, Ioannou PV, Frederik P, Antimisiaris SG (2005) Arsonoliposomes: effect of lipid composition on their stability. J Liposome Res 15:187–197

    Article  CAS  PubMed  Google Scholar 

  12. Fatouros DG, Piperoudi S, Gortzi O, Ioannou PV, Frederik P, Antimisiaris SG (2005) Physical stability of sonicated arsonoliposomes: effect of calcium ions. J Pharm Sci 94:46–55

    Article  CAS  PubMed  Google Scholar 

  13. Antimisiaris SG, Klepetsanis P, Zachariou V, Giannopoulou E, Ioannou PV (2005) In vivo distribution of arsenic after i.p. injection of arsonoliposomes in balb-c mice. Int J Pharm 289:151–158

    Article  CAS  PubMed  Google Scholar 

  14. Zagana P, Haikou M, Klepetsanis P, Giannopoulou E, Ioannou PV, Antimisiaris SG (2008) In vivo distribution of arsonoliposomes: effect of vesicle lipid composition. Int J Pharm 347:86–92

    Article  CAS  PubMed  Google Scholar 

  15. Antimisiaris SG, Ioannou PV, Loiseau PM (2003) In vitro antileishmanial and trypanocidal activities of arsonoliposomes and preliminary in vivo distribution. J Pharm Pharmacol 55:647–652

    Article  CAS  PubMed  Google Scholar 

  16. Zagana P, Klepetsanis P, Ioannou PV, Loiseau PM, Antimisiaris SG (2007) Trypanocidal activity of arsonoliposomes: effect of vesicle lipid composition. Biomed Pharmacother 61:499–504

    Article  CAS  PubMed  Google Scholar 

  17. Zagana P, Haikou M, Giannopoulou E, Ioannou PV, Antimisiaris SG (2009) Arsonoliposome interaction with cells in culture. Effect of pegylation and lipid composition. J Mol Nutr Food Res 53:592–599

    Google Scholar 

  18. Gortzi O, Papadimitriou E, Kontoyannis C, Antimisiaris SG, Ioannou PV (2002) Arsonoliposomes, a Novel class of arsenic-containing liposomes: effect of palmitoyl-arsonolipid-containing liposomes on the viability of cancer and normal cells in culture. Pharm Res 19:79–86

    Article  CAS  PubMed  Google Scholar 

  19. Gortzi O, Papadimitriou E, Antimisiaris SG, Ioannou PV (2003) Cytotoxicity of arsonolipid containing liposomes towards cancer and normal cells in culture: effect of arsonolipid acyl chain length. Eur J Pharm Sci 18:175–183

    Article  CAS  PubMed  Google Scholar 

  20. Cleland M, Allen T (1981) Serum induced leakage of liposome entrapped contents. Biochim Biophys Acta 597:418–426

    Google Scholar 

  21. Stewart JCM (1980) Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem 104:10–14

    Article  CAS  PubMed  Google Scholar 

  22. Desaulniers JAH, Sturgeon RE, Berman SS (1985) Atomic absorption determination of trace metals in marine sediments and biological tissues using a stabilized temperature platform furnace. At Spectrosc 6:125–127

    CAS  Google Scholar 

  23. Senior J, Gregoriadis G (1982) Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipids and cholesterol components. Life Sci 30:2123–2136

    Article  CAS  PubMed  Google Scholar 

  24. Wilschut J, Duzgunes N, Hong K, Hoekstra D, Papahadjopoulos D (1983) Retention of aqueous contents during divalent cation-induced fusion of phospholipid vesicles. Biophys Biochim Acta 734:309–318

    Article  CAS  Google Scholar 

  25. Fatouros D, Ioannou PV, Antimisiaris SG (2006) Novel nanosized arsenic containing vesicles for drug delivery: arsonoliposomes. J Nanosci Nanotechnol 6:2618–2687

    Article  CAS  PubMed  Google Scholar 

  26. Antimisiaris SG (2007) Arsonoliposomes for drug delivery. J Drug Deliv Sci Technol 17:377–388

    CAS  Google Scholar 

Download references

Acknowledgments

Part of the work presented in this review was partly supported by the General Secretariat of Research and Technology, Athens Greece (PENED 95).

The authors would like to thank all the scientists that have contributed in this on-going research, and especially, Prof D. Fatouros, Prof. P. Loiseau, Prof. P. Frederik and Prof. P. Klepetsanis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sophia G. Antimisiaris .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Humana Press, a part of Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Antimisiaris, S.G., Ioannou, P.V. (2010). Arsonoliposomes: Preparation and Physicochemical Characterization. In: Weissig, V. (eds) Liposomes. Methods in Molecular Biology, vol 605. Humana Press. https://doi.org/10.1007/978-1-60327-360-2_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-360-2_10

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-359-6

  • Online ISBN: 978-1-60327-360-2

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics